jtt 501 has been researched along with leptin in 1 studies
Studies (jtt 501) | Trials (jtt 501) | Recent Studies (post-2010) (jtt 501) | Studies (leptin) | Trials (leptin) | Recent Studies (post-2010) (leptin) |
---|---|---|---|---|---|
21 | 0 | 1 | 25,940 | 1,628 | 11,468 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Matsui, K; Shibata, T; Wakitani, K; Yonemori, F | 1 |
1 other study(ies) available for jtt 501 and leptin
Article | Year |
---|---|
JTT-501, a novel oral antidiabetic agent, improves insulin resistance in genetic and non-genetic insulin-resistant models.
Topics: Animals; Blood Glucose; Disease Models, Animal; Glucose; Glucose Clamp Technique; Glucose Tolerance Test; Hyperglycemia; Hypoglycemic Agents; Infusions, Intravenous; Insulin; Insulin Resistance; Isoxazoles; Leptin; Lipids; Male; Obesity; Oxidation-Reduction; Phosphorylation; Proteins; Rats; Rats, Sprague-Dawley; Rats, Zucker; Receptor, Insulin; Triglycerides | 1998 |